Abstract

The quantitative benefit of ICD therapy in patients with malignant ventricular tachyarrhythmia with different degrees of left ventricular dysfunction is unclear. We evaluated patterns of ICD use and survival in 112 patients with moderate to severe left ventricular dysfunction. Group 1 included 57 patients with moderate left ventricular dysfunction (defined as left ventricular ejection fraction greater than 30%) and group 2 comprised 55 patients with severe left ventricular dysfunction (defined as ejection fraction equal to or less than 30%). The follow-up period ranged from 1 to 78 months. Age, incidence of coronary artery disease, and presenting arrhythmia in the two groups were similar. The mean left ventricular ejection fraction in group 1 was 44.6 ± 8.2% and in group 2 was 21.6 ± 6% ( p < 0.0001). At 3 years of follow-up 65% of the patients in group 1 and 71% in group 2 ( p =NS) had ICD activation for presumed ventricular tachycardia. Survival was calculated by means of actuarial analysis. Arrhythmia or sudden death mortality at 4 years of follow-up was 5% in group 1 and 9% in group 2 (NS). Cardiac mortality was higher in patients with severe left ventricular dysfunction reaching levels of statistical significance at 2 years of follow-up. At 2 years of follow-up it was 12% in group 1 and 40% in group 2 ( p = 0.05), and at 4 years of follow-up it was 15% in group 1 and 43% in group 2 ( p < 0.01). In both groups there was no difference in cardiac mortality in patients who did and did not have appropriate ICD shocks. We conclude that the observed incidence of long-term ICD use is comparable in patients with moderate and severe left ventricular dysfunction. However, cardiac mortality is higher in patients with severe left ventricular dysfunction regardless of device use. The long-term clinical outcome of ICD device users and nonusers in these two subgroups with different degrees of left ventricular dysfunction is comparable. This can be related to elimination of arrhythmic mortality by the ICD in patients with left ventricular dysfunction and recurrent ventricular tachyarrhythmias.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.